ALLMedicine™ Liver Biopsy Center
Research & Reviews 3,093 results
https://clinicaltrials.gov/ct2/show/NCT00001971
May 13th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...
https://clinicaltrials.gov/ct2/show/NCT03520660
May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...
https://clinicaltrials.gov/ct2/show/NCT05370053
May 11th, 2022 - Background: During the hepatology evaluation, vibration-controlled transient elastography (VCTE) is often used as a clinical decision aid to target high-risk patients for liver biopsy. The enhanced liver fibrosis (ELF) test is expected to be appro...
https://clinicaltrials.gov/ct2/show/NCT05361044
May 10th, 2022 - With the increasing shortage of available donor organs, liver transplantation from donation after circulatory death (DCD) has been established in many countries to offer a therapeutic strategy for patients with end-stage liver disease beyond stand...
https://doi.org/10.1007/s40519-022-01400-y 10.1016/S0140-6736(18)30794-3 10.1007/s00125-020-05140-5 10.1016/j.jhep.2020.03.039 10.1016/j.jhep.2019.06.021 10.1016/j.jhep.2018.05.036 10.1002/ncp.10449 10.1016/j.jhep.2020.07.020 10.4093/dmj.2019.0011 10.1016/j.jhep.2021.05.025 10.1136/bmjdrc-2019-000904 10.14309/ajg.0000000000001054 10.1111/cen.14043 10.1007/s13679-015-0153-z 10.1037/amp0000538 10.1002/hep.20734 10.1053/j.gastro.2009.06.005 10.1002/hep.21178 10.1136/gut.2007.146019 10.1053/jhep.2002.36128 10.1016/S0016-5085(00)70364-7 10.1111/j.1751-2980.2012.00631 10.1136/gut.2010.216077 10.1080/07315724.2016.1264280 10.3109/07853890.2010.518623 10.1002/hep.21669 10.1016/j.cgh.2009.05.033 10.1007/s10620-007-9924-z 10.1136/gut.2010.216077 10.1038/nrendo.2017.173 10.1097/MCG.0000000000000905 10.1007/s40618-020-01188-7 10.1002/hep.28394 10.1016/j.dld.2009.08.002 10.1002/hep.24105
Eating and Weight Disorders : EWD; Melania G, Luisella V et. al.
May 9th, 2022 - The non-invasive assessment of steatosis/fibrosis tried to overcome some of peri-procedural risk of liver biopsy; for this, several indices of steatosis and fibrosis in liver have been proposed. To evaluate concordance of non-invasive fibrosis and...
Guidelines 12 results
https://doi.org/10.1016/j.clinre.2021.101765
Clinics and Research in Hepatology and Gastroenterology; Nault JC, Blanc JF et. al.
Aug 2nd, 2021 - Hepatocellular benign liver tumours are mainly developed on normal liver and include hepatic hemangioma, focal nodular hyperplasia and hepatocellular adenoma from the most frequent to the less frequent. The diagnosis of hepatic hemangioma and of s...
https://doi.org/10.1016/j.clinre.2021.101771
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.
Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and i...
https://doi.org/10.1016/j.clinre.2021.101762
Clinics and Research in Hepatology and Gastroenterology; Bardou-Jacquet E, Hamdi-Roze H et. al.
Aug 1st, 2021 - Increased serum ferritin is a very frequent cause of referral for which thorough evaluation is required to avoid unnecessary exploration and inaccurate diagnosis. Clinicians must thus know factors and tools that are relevant in this setting. Sever...
https://doi.org/10.1016/j.clinre.2021.101774
Clinics and Research in Hepatology and Gastroenterology; Dumortier J, Besch C et. al.
Aug 1st, 2021 - The field of liver transplantation directly or indirectly embodies all liver diseases, in addition to specific ones related to organ rejection (cellular and humoral). The recommended non-invasive methods for determining the indication for liver tr...
https://doi.org/10.1016/j.clinre.2021.101764
Clinics and Research in Hepatology and Gastroenterology; Rautou PE, Elkrief L et. al.
Aug 1st, 2021 - Vascular disorders of the liver are rare diseases, some of which are diagnosed mainly with non-invasive tests and others by liver biopsy. Non-invasive methods can be used to diagnose and monitor these diseases. However, their evaluation needs to b...
Drugs 9 results see all →
Clinicaltrials.gov 185 results
https://clinicaltrials.gov/ct2/show/NCT03520660
May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...
https://clinicaltrials.gov/ct2/show/NCT00001971
May 13th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...
https://clinicaltrials.gov/ct2/show/NCT05370053
May 11th, 2022 - Background: During the hepatology evaluation, vibration-controlled transient elastography (VCTE) is often used as a clinical decision aid to target high-risk patients for liver biopsy. The enhanced liver fibrosis (ELF) test is expected to be appro...
https://clinicaltrials.gov/ct2/show/NCT05361044
May 10th, 2022 - With the increasing shortage of available donor organs, liver transplantation from donation after circulatory death (DCD) has been established in many countries to offer a therapeutic strategy for patients with end-stage liver disease beyond stand...
https://clinicaltrials.gov/ct2/show/NCT01943318
May 5th, 2022 - The investigators are planning to recruit patients with liver cirrhosis, and collect the baseline clinical laboratory data. Biological tests, endoscopy,liver ultrasonography (including ARFI) and hepatic venous pressure gradient measurements will b...
News 213 results
https://www.medscape.com/viewarticle/972172
Apr 14th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is an increasingly common, underdiagnosed, and underappreciated independent risk factor for atherosclerotic cardiovascular disease (ASCVD), the American Heart Association (AHA) says in the first-ever scient...
https://www.medscape.com/viewarticle/962366
Nov 5th, 2021 - A noninvasive enhanced liver fibrosis (ELF) blood test identifies patients with nonalcoholic fatty liver disease (NAFLD) who are at increased risk of advanced fibrosis, according to a new study. According to the study researchers, when combined wi...
https://www.medpagetoday.com/gastroenterology/generalhepatology/95164
Oct 20th, 2021 - In patients with non-alcoholic fatty liver disease (NAFLD), advanced fibrosis was associated with a greater risk for liver decompensation and all-cause mortality compared to those with lower stages of fibrosis, a prospective cohort study found. In...
https://www.medscape.com/viewarticle/960399
Oct 7th, 2021 - NEW YORK (Reuters Health) - In patients taking immune checkpoint inhibitors (ICIs) who developed moderate-to-severe liver injury, a biopsy delayed steroid initiation and was not associated with more rapid hepatitis resolution of hepatitis, an obse...
https://www.medscape.com/viewarticle/960338
Oct 6th, 2021 - A combination of magnetic resonance elastography and blood levels of fibrosis-4 index (MEFIB) outperformed FibroScan-AST (FAST) in determining the presence of significant fibrosis among patients with nonalcoholic fatty liver disease (NAFLD), accor...
